Meza-Romero, Roberto
Benedek, Gil
Leng, Lin
Bucala, Richard
Vandenbark, Arthur A.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01 NS047661)
National Multiple Sclerosis Society (RG-5068-A-6, RG5272A1/T)
U.S. Department of Veterans Affairs (5I01BX000226)
National Institutes of Health (AR049610, AI042310)
Article History
Received: 21 December 2015
Accepted: 19 January 2016
First Online: 6 February 2016
Compliance with ethical standards
:
: Drs. Vandenbark, Benedek, Meza-Romero and OHSU have a significant financial interest in Artielle ImmunoTherapeutics, Inc., a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and managed by the OHSU and VAPHCS Conflict of Interest in Research Committees. Drs. Leng and Bucala have no conflict of interest.